Pulmonary AngII promotes LPS-induced lung inflammation by regulating microRNA-143 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-09-03

AUTHORS

Shenglan Wang, Yan Tan, Tingting Yang, Chen Liu, Rufang Li

ABSTRACT

Angiotensin converting enzyme 2 (ACE2) is a terminal carboxypeptidase, which cleaves single terminal residues from several bioactive peptides such as Angiotensin II (AngII). Many investigations indicated that ACE2 functions in angiotensin system and plays a crucial role in inflammatory lung diseases. However, the mechanism behind the involvement of ACE2 in inflammatory lung disease has not been fully elucidated. In this study, BEAS-2B cells were treated with gradient concentration of AngII and lipopolysaccharide (LPS) to induce inflammatory condition. Quantitative RT-PCR was performed to detect the level of ACE2 and miR-143-3p. Western blotting and immunofluorescence assays were performed to measure the expression of related proteins. The levels of inflammatory cytokines and cell viability were respectively measured by ELISA and CCK-8 kits. And ACE2 activity was detected by corresponding commercial kits. Bioinformatics methods were employed to predict the potential microRNA targeting ACE2, which was then confirmed by dual luciferase reporter assay. The results showed that ACE2 expression and activity were time-dependently decreased in LPS group for the first 12 h, after which this tendency was reversed. AngII addition enhanced these effects, compared with LPS group. Additionally, the lowest ACE2 activity level was found in both LPS and AngII + LPS groups at 6 h. The number of nuclei and the ACE2 expression were decreased in LPS groups at 6 h and further reduced by addition of AngII, detected by immunofluorescence. Moreover, ACE2 was validated to be a direct target of miR-143-3p. Pretreatment of AngII and LPS regulated the activity of ACE2, increased the expression of proinflammatory cytokines and cell apoptosis and regulated the expression of Bax, Bcl-2 and cleaved caspase-3 in BEAS-2B cells, which could be reversed by transfecting miR-143-3p inhibitor. The results collectively suggest that AngII promotes LPS-induced inflammation by regulating miR-143-3p in BEAS-2B cells. Therefore, miR-143-3p is considered a potential molecular target for the treatment of lung inflammation. More... »

PAGES

745-754

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10616-021-00493-0

DOI

http://dx.doi.org/10.1007/s10616-021-00493-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1140869326

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34493899


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
          "id": "http://www.grid.ac/institutes/grid.218292.2", 
          "name": [
            "Pulmonary and Critical Care Medicine, The First People\u2019s Hospital of Yunnan Province, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
            "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Shenglan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
          "id": "http://www.grid.ac/institutes/grid.218292.2", 
          "name": [
            "Pulmonary and Critical Care Medicine, The First People\u2019s Hospital of Yunnan Province, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
            "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tan", 
        "givenName": "Yan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
          "id": "http://www.grid.ac/institutes/grid.218292.2", 
          "name": [
            "Pulmonary and Critical Care Medicine, The First People\u2019s Hospital of Yunnan Province, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
            "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Tingting", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
          "id": "http://www.grid.ac/institutes/grid.218292.2", 
          "name": [
            "Pulmonary and Critical Care Medicine, The First People\u2019s Hospital of Yunnan Province, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
            "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Chen", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
          "id": "http://www.grid.ac/institutes/grid.218292.2", 
          "name": [
            "Pulmonary and Critical Care Medicine, The First People\u2019s Hospital of Yunnan Province, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China", 
            "The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Rufang", 
        "id": "sg:person.012556012263.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012556012263.60"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00011-015-0805-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038339524", 
          "https://doi.org/10.1007/s00011-015-0805-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature02145", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040468747", 
          "https://doi.org/10.1038/nature02145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41434-020-00210-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1132542719", 
          "https://doi.org/10.1038/s41434-020-00210-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature03712", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003644008", 
          "https://doi.org/10.1038/nature03712"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41598-016-0023-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085379168", 
          "https://doi.org/10.1038/s41598-016-0023-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10787-018-0535-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1107414856", 
          "https://doi.org/10.1007/s10787-018-0535-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm2632", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009902558", 
          "https://doi.org/10.1038/nrm2632"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-09-03", 
    "datePublishedReg": "2021-09-03", 
    "description": "Angiotensin converting enzyme 2 (ACE2) is a terminal carboxypeptidase, which cleaves single terminal residues from several bioactive peptides such as Angiotensin II (AngII). Many investigations indicated that ACE2 functions in angiotensin system and plays a crucial role in inflammatory lung diseases. However, the mechanism behind the involvement of ACE2 in inflammatory lung disease has not been fully elucidated. In this study, BEAS-2B cells were treated with gradient concentration of AngII and lipopolysaccharide (LPS) to induce inflammatory condition. Quantitative RT-PCR was performed to detect the level of ACE2 and miR-143-3p. Western blotting and immunofluorescence assays were performed to measure the expression of related proteins. The levels of inflammatory cytokines and cell viability were respectively measured by ELISA and CCK-8 kits. And ACE2 activity was detected by corresponding commercial kits. Bioinformatics methods were employed to predict the potential microRNA targeting ACE2, which was then confirmed by dual luciferase reporter assay. The results showed that ACE2 expression and activity were time-dependently decreased in LPS group for the first 12\u00a0h, after which this tendency was reversed. AngII addition enhanced these effects, compared with LPS group. Additionally, the lowest ACE2 activity level was found in both LPS and AngII + LPS groups at 6\u00a0h. The number of nuclei and the ACE2 expression were decreased in LPS groups at 6\u00a0h and further reduced by addition of AngII, detected by immunofluorescence. Moreover, ACE2 was validated to be a direct target of miR-143-3p. Pretreatment of AngII and LPS regulated the activity of ACE2, increased the expression of proinflammatory cytokines and cell apoptosis and regulated the expression of Bax, Bcl-2 and cleaved caspase-3 in BEAS-2B cells, which could be reversed by transfecting miR-143-3p inhibitor. The results collectively suggest that AngII promotes LPS-induced inflammation by regulating miR-143-3p in BEAS-2B cells. Therefore, miR-143-3p is considered a potential molecular target for the treatment of lung inflammation.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10616-021-00493-0", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1086307", 
        "issn": [
          "1381-5741", 
          "1573-0603"
        ], 
        "name": "Cytotechnology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "73"
      }
    ], 
    "keywords": [
      "inflammatory lung diseases", 
      "BEAS-2B cells", 
      "LPS group", 
      "ACE2 expression", 
      "lung inflammation", 
      "lung disease", 
      "levels of ACE2", 
      "addition of AngII", 
      "activity of ACE2", 
      "dual-luciferase reporter", 
      "potential molecular targets", 
      "CCK-8 kit", 
      "expression of Bax", 
      "angiotensin system", 
      "quantitative RT-PCR", 
      "ACE2 activity", 
      "proinflammatory cytokines", 
      "angiotensin II", 
      "inflammatory cytokines", 
      "inflammatory conditions", 
      "enzyme 2", 
      "AngII", 
      "ACE2", 
      "ACE2 function", 
      "LPS", 
      "inflammation", 
      "immunofluorescence assays", 
      "Western blotting", 
      "cell apoptosis", 
      "RT-PCR", 
      "luciferase reporter", 
      "molecular targets", 
      "activity levels", 
      "Bcl-2", 
      "microRNA-143", 
      "caspase-3", 
      "direct target", 
      "cytokines", 
      "cell viability", 
      "disease", 
      "commercial kits", 
      "potential microRNAs", 
      "group", 
      "bioactive peptides", 
      "expression", 
      "cells", 
      "kit", 
      "angiotensin", 
      "levels", 
      "number of nuclei", 
      "related proteins", 
      "ELISA", 
      "activity", 
      "gradient concentration", 
      "immunofluorescence", 
      "blotting", 
      "crucial role", 
      "target", 
      "treatment", 
      "apoptosis", 
      "inhibitors", 
      "Bax", 
      "involvement", 
      "pretreatment", 
      "assays", 
      "bioinformatics methods", 
      "microRNAs", 
      "peptides", 
      "reporter", 
      "addition", 
      "viability", 
      "study", 
      "protein", 
      "role", 
      "nucleus", 
      "effect", 
      "concentration", 
      "results", 
      "carboxypeptidase", 
      "mechanism", 
      "terminal residues", 
      "function", 
      "number", 
      "time", 
      "investigation", 
      "tendency", 
      "conditions", 
      "method", 
      "system", 
      "residues", 
      "terminal carboxypeptidase", 
      "single terminal residues", 
      "involvement of ACE2", 
      "lowest ACE2 activity level", 
      "ACE2 activity level", 
      "Pretreatment of AngII", 
      "Pulmonary AngII"
    ], 
    "name": "Pulmonary AngII promotes LPS-induced lung inflammation by regulating microRNA-143", 
    "pagination": "745-754", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1140869326"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10616-021-00493-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34493899"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10616-021-00493-0", 
      "https://app.dimensions.ai/details/publication/pub.1140869326"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T19:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_877.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10616-021-00493-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10616-021-00493-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10616-021-00493-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10616-021-00493-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10616-021-00493-0'


 

This table displays all metadata directly associated to this object as RDF triples.

212 TRIPLES      22 PREDICATES      130 URIs      115 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10616-021-00493-0 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nb51aba28e15047a38eaadcdcae1d36a8
4 schema:citation sg:pub.10.1007/s00011-015-0805-1
5 sg:pub.10.1007/s10787-018-0535-4
6 sg:pub.10.1038/nature02145
7 sg:pub.10.1038/nature03712
8 sg:pub.10.1038/nrm2632
9 sg:pub.10.1038/s41434-020-00210-0
10 sg:pub.10.1038/s41598-016-0023-2
11 schema:datePublished 2021-09-03
12 schema:datePublishedReg 2021-09-03
13 schema:description Angiotensin converting enzyme 2 (ACE2) is a terminal carboxypeptidase, which cleaves single terminal residues from several bioactive peptides such as Angiotensin II (AngII). Many investigations indicated that ACE2 functions in angiotensin system and plays a crucial role in inflammatory lung diseases. However, the mechanism behind the involvement of ACE2 in inflammatory lung disease has not been fully elucidated. In this study, BEAS-2B cells were treated with gradient concentration of AngII and lipopolysaccharide (LPS) to induce inflammatory condition. Quantitative RT-PCR was performed to detect the level of ACE2 and miR-143-3p. Western blotting and immunofluorescence assays were performed to measure the expression of related proteins. The levels of inflammatory cytokines and cell viability were respectively measured by ELISA and CCK-8 kits. And ACE2 activity was detected by corresponding commercial kits. Bioinformatics methods were employed to predict the potential microRNA targeting ACE2, which was then confirmed by dual luciferase reporter assay. The results showed that ACE2 expression and activity were time-dependently decreased in LPS group for the first 12 h, after which this tendency was reversed. AngII addition enhanced these effects, compared with LPS group. Additionally, the lowest ACE2 activity level was found in both LPS and AngII + LPS groups at 6 h. The number of nuclei and the ACE2 expression were decreased in LPS groups at 6 h and further reduced by addition of AngII, detected by immunofluorescence. Moreover, ACE2 was validated to be a direct target of miR-143-3p. Pretreatment of AngII and LPS regulated the activity of ACE2, increased the expression of proinflammatory cytokines and cell apoptosis and regulated the expression of Bax, Bcl-2 and cleaved caspase-3 in BEAS-2B cells, which could be reversed by transfecting miR-143-3p inhibitor. The results collectively suggest that AngII promotes LPS-induced inflammation by regulating miR-143-3p in BEAS-2B cells. Therefore, miR-143-3p is considered a potential molecular target for the treatment of lung inflammation.
14 schema:genre article
15 schema:inLanguage en
16 schema:isAccessibleForFree true
17 schema:isPartOf N4cc3ecabe09742d197b20349e12a1803
18 Nce77d144ff6e41c29a577ecc21d3c80b
19 sg:journal.1086307
20 schema:keywords ACE2
21 ACE2 activity
22 ACE2 activity level
23 ACE2 expression
24 ACE2 function
25 AngII
26 BEAS-2B cells
27 Bax
28 Bcl-2
29 CCK-8 kit
30 ELISA
31 LPS
32 LPS group
33 Pretreatment of AngII
34 Pulmonary AngII
35 RT-PCR
36 Western blotting
37 activity
38 activity levels
39 activity of ACE2
40 addition
41 addition of AngII
42 angiotensin
43 angiotensin II
44 angiotensin system
45 apoptosis
46 assays
47 bioactive peptides
48 bioinformatics methods
49 blotting
50 carboxypeptidase
51 caspase-3
52 cell apoptosis
53 cell viability
54 cells
55 commercial kits
56 concentration
57 conditions
58 crucial role
59 cytokines
60 direct target
61 disease
62 dual-luciferase reporter
63 effect
64 enzyme 2
65 expression
66 expression of Bax
67 function
68 gradient concentration
69 group
70 immunofluorescence
71 immunofluorescence assays
72 inflammation
73 inflammatory conditions
74 inflammatory cytokines
75 inflammatory lung diseases
76 inhibitors
77 investigation
78 involvement
79 involvement of ACE2
80 kit
81 levels
82 levels of ACE2
83 lowest ACE2 activity level
84 luciferase reporter
85 lung disease
86 lung inflammation
87 mechanism
88 method
89 microRNA-143
90 microRNAs
91 molecular targets
92 nucleus
93 number
94 number of nuclei
95 peptides
96 potential microRNAs
97 potential molecular targets
98 pretreatment
99 proinflammatory cytokines
100 protein
101 quantitative RT-PCR
102 related proteins
103 reporter
104 residues
105 results
106 role
107 single terminal residues
108 study
109 system
110 target
111 tendency
112 terminal carboxypeptidase
113 terminal residues
114 time
115 treatment
116 viability
117 schema:name Pulmonary AngII promotes LPS-induced lung inflammation by regulating microRNA-143
118 schema:pagination 745-754
119 schema:productId N0404d89cb8b24245867ea89fdaaedda7
120 N2661bd3f849d4c549951191a5d6a324f
121 Nb748e5715b4c4ee1a32dd09b9216cded
122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1140869326
123 https://doi.org/10.1007/s10616-021-00493-0
124 schema:sdDatePublished 2022-01-01T19:00
125 schema:sdLicense https://scigraph.springernature.com/explorer/license/
126 schema:sdPublisher N9fce7348b1db4c1ab6bb53770ab67a04
127 schema:url https://doi.org/10.1007/s10616-021-00493-0
128 sgo:license sg:explorer/license/
129 sgo:sdDataset articles
130 rdf:type schema:ScholarlyArticle
131 N0404d89cb8b24245867ea89fdaaedda7 schema:name dimensions_id
132 schema:value pub.1140869326
133 rdf:type schema:PropertyValue
134 N2661bd3f849d4c549951191a5d6a324f schema:name pubmed_id
135 schema:value 34493899
136 rdf:type schema:PropertyValue
137 N26fc76e20e864071ba69654c69d982e3 rdf:first Ne0c865d341a747a5a4f3638691154bf0
138 rdf:rest Nd8eaac40b831428fbc88588d85db51f4
139 N4cc3ecabe09742d197b20349e12a1803 schema:issueNumber 5
140 rdf:type schema:PublicationIssue
141 N59cbbfbb0eae4b9390fbe91f3a9b529a rdf:first N80ba4c4bd4bd4cc3ac67f11963aff0b9
142 rdf:rest Na9136aec5be64409bf6f44f824fb306c
143 N80ba4c4bd4bd4cc3ac67f11963aff0b9 schema:affiliation grid-institutes:grid.218292.2
144 schema:familyName Tan
145 schema:givenName Yan
146 rdf:type schema:Person
147 N8a82447456894b87804bb9db647ed06a schema:affiliation grid-institutes:grid.218292.2
148 schema:familyName Wang
149 schema:givenName Shenglan
150 rdf:type schema:Person
151 N9fce7348b1db4c1ab6bb53770ab67a04 schema:name Springer Nature - SN SciGraph project
152 rdf:type schema:Organization
153 Na9136aec5be64409bf6f44f824fb306c rdf:first Ncb4fa08ccdcf45489157ac2fd140beb4
154 rdf:rest N26fc76e20e864071ba69654c69d982e3
155 Nb51aba28e15047a38eaadcdcae1d36a8 rdf:first N8a82447456894b87804bb9db647ed06a
156 rdf:rest N59cbbfbb0eae4b9390fbe91f3a9b529a
157 Nb748e5715b4c4ee1a32dd09b9216cded schema:name doi
158 schema:value 10.1007/s10616-021-00493-0
159 rdf:type schema:PropertyValue
160 Ncb4fa08ccdcf45489157ac2fd140beb4 schema:affiliation grid-institutes:grid.218292.2
161 schema:familyName Yang
162 schema:givenName Tingting
163 rdf:type schema:Person
164 Nce77d144ff6e41c29a577ecc21d3c80b schema:volumeNumber 73
165 rdf:type schema:PublicationVolume
166 Nd8eaac40b831428fbc88588d85db51f4 rdf:first sg:person.012556012263.60
167 rdf:rest rdf:nil
168 Ne0c865d341a747a5a4f3638691154bf0 schema:affiliation grid-institutes:grid.218292.2
169 schema:familyName Liu
170 schema:givenName Chen
171 rdf:type schema:Person
172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
173 schema:name Medical and Health Sciences
174 rdf:type schema:DefinedTerm
175 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
176 schema:name Cardiorespiratory Medicine and Haematology
177 rdf:type schema:DefinedTerm
178 sg:journal.1086307 schema:issn 1381-5741
179 1573-0603
180 schema:name Cytotechnology
181 schema:publisher Springer Nature
182 rdf:type schema:Periodical
183 sg:person.012556012263.60 schema:affiliation grid-institutes:grid.218292.2
184 schema:familyName Li
185 schema:givenName Rufang
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012556012263.60
187 rdf:type schema:Person
188 sg:pub.10.1007/s00011-015-0805-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038339524
189 https://doi.org/10.1007/s00011-015-0805-1
190 rdf:type schema:CreativeWork
191 sg:pub.10.1007/s10787-018-0535-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107414856
192 https://doi.org/10.1007/s10787-018-0535-4
193 rdf:type schema:CreativeWork
194 sg:pub.10.1038/nature02145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040468747
195 https://doi.org/10.1038/nature02145
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/nature03712 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003644008
198 https://doi.org/10.1038/nature03712
199 rdf:type schema:CreativeWork
200 sg:pub.10.1038/nrm2632 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009902558
201 https://doi.org/10.1038/nrm2632
202 rdf:type schema:CreativeWork
203 sg:pub.10.1038/s41434-020-00210-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132542719
204 https://doi.org/10.1038/s41434-020-00210-0
205 rdf:type schema:CreativeWork
206 sg:pub.10.1038/s41598-016-0023-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085379168
207 https://doi.org/10.1038/s41598-016-0023-2
208 rdf:type schema:CreativeWork
209 grid-institutes:grid.218292.2 schema:alternateName The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China
210 schema:name Pulmonary and Critical Care Medicine, The First People’s Hospital of Yunnan Province, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China
211 The Affiliated Hospital of Kunming University of Science and Technology, 157 Jinbi Road, Xishan District, Kunming, 650032 Yunnan China
212 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...